Rosuvastatin Calcium Tablet
Product Images NDC 71610-801

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 71610-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 801 45)

FDA Label Image

Aphena (Aphena)

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Figure2.jpg (Figure2)

This text provides information on cumulative incidence, where the value is 9%. Additionally, it includes details on hazard ratio (HR) which is 0.56 with a 95% confidence interval between 0.46 and 0.68. The p-value is less than 0.001, indicating statistical significance.*

FDA Label Image

Figure3.jpg (Figure3)

FDA Label Image

Structure-formula.jpg (Structure Formula)

FDA Label Image

Table1.jpg (Table1)

This is data comparing the adverse effects experienced by individuals taking different medications. The table shows the percentage of participants who reported specific side effects such as headache, nausea, fatigue, constipation, and others, for each medication being studied. The results suggest that medication "Adverse" has higher rates of nausea and constipation compared to the placebo, while experiencing less headache. On the other hand, medication "Rasusv:lslalln" shows higher rates of fatigue compared to other medications and placebo.*

FDA Label Image

Table10.jpg (Table10)

FDA Label Image

Table12.jpg (Table12)

FDA Label Image

Table2.jpg (Table2)

This text provides information on adverse reactions associated with the drug Rosuvastatin 40 mg. The data includes the number of patients experiencing various side effects such as myalgia, arthralgia, headache, dizziness, increased C-reactive protein (CPR), abdominal pain, and abnormal liver function tests (>3xULN).*

FDA Label Image

Table3.jpg (Table3)

This is a list of adverse reactions associated with Rosuvastatin 20 mg tablets. Common side effects include myalgia (muscle pain), arthralgia (joint pain), constipation, diabetes mellitus, and nausea. The numbers represent the frequency of each reported side effect.*

FDA Label Image

Table4.jpg (Table4)

FDA Label Image

Table5.jpg (Table5)

FDA Label Image

Table6.jpg (Table6)

This text appears to contain data related to the effects of different doses of Rosuvastatin on various lipid levels and biomarkers. The data shows changes in LDL-C, Non-HDL-C, ApoB, and HDL-C levels at different doses of Rosuvastatin compared to a placebo. The values indicate the impact of each dose on these parameters. This information can be used to understand the efficacy and dose-response relationship of Rosuvastatin in managing cholesterol levels.*

FDA Label Image

Table7.jpg (Table7)

This is a table showing the daily doses of different statin medications. The table includes the medications Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin, with varying dose strengths ranging from 10 mg to 80 mg. The values in the table represent the daily dose adjustments for each medication.*

FDA Label Image

Table8.jpg (Table8)

FDA Label Image

Table9.jpg (Table9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.